-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QjNssSbc/Qdp+GcT60mwuuE8etCj8ILLviMNSKKE2FnW14sxurOi5Ywu1gUL65DN nnzrQdrFAbSZG7yg/hgjKA== 0001021088-99-000002.txt : 19990107 0001021088-99-000002.hdr.sgml : 19990107 ACCESSION NUMBER: 0001021088-99-000002 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990106 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-40113 FILM NUMBER: 99501517 BUSINESS ADDRESS: STREET 1: 4830 WEST KENNEDY BLVD STREET 2: SUITE 548 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: 8132864401 MAIL ADDRESS: STREET 1: 4830 WEST KENNEDY BLVD STREET 2: SUITE 548 CITY: TAMPA STATE: FL ZIP: 33609 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PERRY JOHN F /GA/ CENTRAL INDEX KEY: 0001053522 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 066328649 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 95 NORTH MILL ROAD CITY: ATLANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 4042525581 MAIL ADDRESS: STREET 1: 95 NORTH MILL ROAD CITY: ATLANTA STATE: GA ZIP: 30328 SC 13D/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO SCHEDULE 13D/A Under the Securities Exchange Act of 1934 BENTLEY PHARMACEUTICALS, INC. - ------------------------------------------------------------------ (Name of Issuer) Common Stock, Par Value $.02 per Share - ------------------------------------------------------------------ (Title of Class of Securities) 082657107 -------------------------- (CUSIP Number) John F. Perry, 95 North Mill Road, Atlanta, GA 30328, (404) 250-9302 - ------------------------------------------------------------------ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 2, 1998 --------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. Check the following box if a fee is being paid with the statement / X /. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ------------------------------------------------------------------------------ SCHEDULE 13D/A CUSIP No. 082657107 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON JOHN F. PERRY, EXECUTOR OF THE ESTATE OF RICHARD C. PERRY - ------------------------------------------------------------------------------ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) - ------------------------------------------------------------------------------ 3. SEC USE ONLY - ------------------------------------------------------------------------------ 4. SOURCE OF FUNDS* 00 - ------------------------------------------------------------------------------ 5. CHECK BOX IF CLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) - ------------------------------------------------------------------------------ 6. CITIZENSHIP OR PLACE OF ORGANIZATION USA - ------------------------------------------------------------------------------ NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH - ------------------------------------------------------------------------------ 7. SOLE VOTING POWER 925,000 - ------------------------------------------------------------------------------ 8. SHARED VOTING POWER - ------------------------------------------------------------------------------ 9. SOLE DISPOSITIVE POWER 925,000 - ------------------------------------------------------------------------------ 10. SHARED DISPOSITIVE POWER - ------------------------------------------------------------------------------ 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 925,000 - ------------------------------------------------------------------------------ 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------ 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11.0% - ------------------------------------------------------------------------------ 14. TYPE OF REPORTING PERSON* OO, IN - ------------------------------------------------------------------------------ - ------------------------------------------------------------------------------ Item 1. Security and Issuer The class of securities to which this amended Schedule 13D relates is the common stock, par value $.02 per share (the "Stock"), of Bentley Pharmaceuticals, Inc., a Florida corporation (the "Company"), whose address is: 1 Urban Center, Suite 550 4830 West Kennedy Boulevard Tampa, FL 33609 - ------------------------------------------------------------------------------ Item 2. Identity and Background a. John F. Perry, Executor of the Estate of Richard C. Perry (the "reporting person"). b. Business Address: 95 North Mill Road, Atlanta, Georgia 30328. c. John F. Perry is the brother of Richard C. Perry, deceased, and is the executor of his estate (the "Estate"). John F. Perry is also President of Perry & Co. (an insurance premium finance management company), 2635 Century Parkway, N.E., Suite 1000, Atlanta, Georgia 30345. d. The reporting person has never been the subject of a criminal proceeding (excluding traffic violations or similar misdemeanors). e. The reporting person is not and has never been subject to any judgment, decree or order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. - ------------------------------------------------------------------------------ Item 3. Source and Amount of Funds or Other Consideration All acquisitions of the Stock have been made by exercising warrants with a combination of funds from the Estate and bank loans made in the ordinary course of business. - ------------------------------------------------------------------------------ Item 4. Purpose of Transaction The Stock previously acquired by the Estate has been purchased for investment purposes. The Estate may make additional purchases or may dispose of some or all of the Stock owned by it in the future in amounts and at times which have not been determined. The Estate has no present plans with regard to the Company other than as an investor in the Stock. - ------------------------------------------------------------------------------ Item 5. Interest in Securities of the Issuer a. The Estate is presently the beneficial owner of 1,325,000 shares of common stock (the "Stock"), believed by the reporting person to represent 11.0% of the issued and outstanding shares of common stock of the Company. b. The reporting person, as executor of the Estate, has sole voting power and sole power to dispose or direct the disposition of the stock and sole right on behalf of the Estate to receive dividends from or proceeds from the sale of the Stock. c. All shares beneficially owned by the Estate were acquired in open market transactions or through the exercise of warrants acquired in open market transactions. On December 2, 1998, the Estate sold in private transactions the following securities: Name Class of Stock Amount --------------------- ---------------- --------- Michael McGovern Common 350,000 Michael McGovern Class B Warrants 2,000,000 Renaissance US Growth and Income Fund III Common 400,000 Renaissance US Growth and Income Trust PLC Common 400,000 John F. Chappell Common 100,000 Eddie Liu Common 40,000 d. No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. e. Not applicable - ------------------------------------------------------------------------------ Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer Except as otherwise described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the reporting person and any other person with respect to the securities of the Company. - ------------------------------------------------------------------------------ Item 7. Material to be Filed as Exhibits There are no exhibits with this Amendment No. 3. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 15, 1998 - ----------------------- Date /s/ John F. Perry --------------------------------- Signature John F. Perry, Executor of Estate of Richard C. Perry --------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----